SWITZERLAND –Switzerland’s Healiva, a chronic wound-focused company, has acquired two new cell therapy assets from UK-based medical technology firm Smith+Nephew for an undisclosed sum. The transaction will enable the Swiss…
Read MoreHealiva expands wound care portfolio by acquiring Smith+Nephew’s cell therapy assets
